News Briefs: SGR Repeal Passes House; Sorin Buy; TriVascular IPO
This article was originally published in The Gray Sheet
House passes legislation to repeal the Medical sustainable growth rate formula for physician payments, but with an Obamacare individual mandate delay that will not likely succeed in the Senate. Sorin buys Oscor’s CRM lead business. TriVascular Technologies moves toward initial public offering. More news.
You may also be interested in...
Senate Finance and House Ways and Means Committee lawmakers issued a revised proposal to overhaul the physician payment sustainable growth rate formula in advance of a Dec. 13 markup. In response to public comment, lawmakers included more restrictions on which imaging services might be subject to appropriate-use criteria requirements.
As sector awaits its aducanumab filing with bated breath, Biogen invests again in early stage neuroscience.
In case you missed it: catch up with snippets from interviews with industry leaders recently published by In Vivo.